|[February 28, 2013]
Research and Markets: Vaccines Partnering Yearbook 2013 Provides Comprehensive Understanding and Unprecedented Access to the Partnering Deals and Agreements
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/vxn82c/vaccines)
has announced the addition of the "Vaccines
Partnering Yearbook 2013" report to their offering.
The Vaccines Partnering Yearbook 2013 report series provides
comprehensive understanding and unprecedented access to the partnering
deals and agreements entered into by the worlds leading healthcare
companies during 2012.
Using these reports, dealmakers will effectively and efficiently gain
insight into the partnering activities of the past year. The report
series allows you to view all the partnering and alliances deals
The report series also includes numerous tables and figures that
illustrate the trends and activities in bigpharma partnering and
dealmaking during 2012.
In conclusion, this report provides everything a prospective dealmaker
needs to know about partnering in the research, development and
commercialization of technologies and products during 2012.
Vaccine Partnering Yearbook 2013 series is intended to provide the
reader with an in-depth understanding and access to partnering trends
and structure of deals entered into by leading companies worldwide.
Vaccine Partnering Yearbook 2013 includes:
- Trends in dealmaking in the biopharma industry during 2012
- Comprehensive directory of partnering deals in 2012
- Links to online access to all deals and alliances
- The leading partnering deals by value in 2012
- Most active partnering dealmakers during 2012
In Vaccine Partnering Yearbook 2012 series the partnering deals are
- Company A-Z
- Headline value
- Stage of development at signing
- Deal component type
- Therapy area
- Technology type
Johnson & Johnson
Kyowa Hakko Kirin
Merck & Co
Mitsubishi (News - Alert) Tanabe
For more information visit http://www.researchandmarkets.com/research/vxn82c/vaccines
[ Back To Technology News's Homepage ]